Carlson Capital’s CureVac CVAC Stock Holding History

Carlson Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,000	Closed	-$299K	–	69
2025 Q2	$299K	Buy	+55,000	New	+$218K	0.12%	59

Other funds holding CVAC

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carlson Capital's CVAC Position: Q3 2025 in Review

Carlson Capital sold out of CureVac (CVAC) in Q3 2025, closing a stake of 55,000 shares — an estimated $299K sold.

Carlson Capital first reported a position in CVAC in Q2 2025 and held it in 1 quarter. The position peaked at $299K in Q2 2025. 94 funds tracked by Wall St. Rank hold CVAC as of Q3 2025.

Carlson Capital reported no remaining CureVac position as of Q3 2025 after selling out during the quarter.
Carlson Capital sold 55,000 CureVac shares in Q3 2025, an estimated $299K.
Carlson Capital first reported a position in CureVac in Q2 2025 and held it in 1 quarter.
Carlson Capital's CureVac position peaked at $299K in Q2 2025.
94 funds tracked by Wall St. Rank held CureVac as of Q3 2025.

Based on Carlson Capital's 13F filing for Q3 2025, filed 5 Nov 2025.